{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:37:12Z","timestamp":1777012632790,"version":"3.51.4"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Activated immune cells can interact with platelets and trigger the coagulation cascade in response to inflammatory stimuli, resulting in the formation of microthrombi which help contain the spread of pathogens, but also contribute to organ dysfunction. Platelet glycoprotein receptor GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      binds to von Willebrand factor and mediates cross-linking of platelets and thrombosis. In the multicenter Thilo trial, we measured plasma levels of GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      to correlate our measurements with the clinical presentation of ARDS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      plasma levels were measured on the first 5\u202fdays after study inclusion in 125 ARDS patients. Plasma levels of GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      of survivors and non-survivors were compared; additionally, we issued a receiver operating characteristics (ROC) curve of GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      levels and performed a survival analysis of patients stratified by their GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      plasma levels. Multivariate Cox analysis was performed to identify risk factors for mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cox analysis showed that low GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      levels were associated with higher mortality. In survivors, GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      levels were significantly higher than in non-survivors. ROC analysis revealed an AUC value of 0.73 for the biomarker. For the Kaplan\u2013Meier curve, patients with the lowest GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      levels (0\u2013130\u202fng\/mL) had a mortality rate of 53%; in patients with higher levels (341\u2013850\u202fng\/mL), the mortality rate was 10%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      We are the first to report a role for platelet GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      as a potential biomarker in ARDS. Lower GPIb-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      plasma levels were associated with a higher mortality rate in ARDS. Diminished plasma levels might point to a higher consumption of the receptor, with an unfavorable effect on overall survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      EUDRA-CT: 2016-003168-37. Registered on 12\/04\/2017.\n                      <jats:uri>ClinicalTrials.gov<\/jats:uri>\n                      : NCT03111212. Registered on 04\/06\/2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1711751","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:33Z","timestamp":1777009293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diminished plasma levels of GPIb-\u03b1 predict mortality in a prospective ARDS cohort"],"prefix":"10.3389","volume":"13","author":[{"given":"Alice","family":"Bernard","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina Maria","family":"Serna-Higuita","sequence":"additional","affiliation":[{"name":"Institute for Clinical Epidemiology and Applied Biostatistics (IKEaB)","place":["T\u00fcbingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Althaus","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty, University Hospital T\u00fcbingen","place":["T\u00fcbingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rosenberger","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"V\u00f6hringer","sequence":"additional","affiliation":[{"name":"Institute for Clinical Epidemiology and Applied Biostatistics (IKEaB)","place":["T\u00fcbingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"K\u00f6rner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Haeberle","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Eggstein","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty, University Hospital T\u00fcbingen","place":["T\u00fcbingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Margraf","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster","place":["M\u00fcnster, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Fodi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster","place":["M\u00fcnster, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koeppen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valbona","family":"Mirakaj","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital","place":["Tuebingen, Germany"]},{"name":"Department of Anaesthesiology, Intensive Care and Pain Therapy, Goethe University Frankfurt, University Hospital Frankfurt","place":["Frankfurt, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","article-title":"Acute respiratory distress syndrome","volume":"398","author":"Meyer","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1182\/blood.2023019940","article-title":"A key role for platelet GPVI in neutrophil recruitment, migration, and NETosis in the early stages of acute lung injury","volume":"142","author":"Burkard","year":"2023","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"953195","DOI":"10.3389\/fimmu.2022.953195","article-title":"The role of neutrophil extracellular traps in acute lung injury","volume":"13","author":"Scozzi","year":"2022","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2250010","DOI":"10.1002\/eji.202250010","article-title":"Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis","volume":"53","author":"Cesta","year":"2023","journal-title":"Eur J Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","article-title":"The role of platelets in immune-mediated inflammatory diseases","volume":"23","author":"Scherlinger","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1165\/rcmb.2017-0420TR","article-title":"Amicus or adversary revisited: platelets in acute lung injury and acute respiratory distress syndrome","volume":"59","author":"Middleton","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ccc.2021.05.003","article-title":"Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury","volume":"37","author":"Swenson","year":"2021","journal-title":"Crit Care Clin"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/jth.12893","article-title":"Platelet and endothelial cell P-selectin are required for host defense against Klebsiella pneumoniae-induced pneumosepsis","volume":"13","author":"de Stoppelaar","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1097\/CCM.0b013e31824e65ba","article-title":"Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway","volume":"40","author":"Piednoir","year":"2012","journal-title":"Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11373-006-9107-5","article-title":"Involvement of platelet glycoprotein Ib in platelet microparticle mediated neutrophil activation","volume":"13","author":"Lo","year":"2006","journal-title":"J Biomed Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0037-1616216","article-title":"The vascular biology of the glycoprotein Ib-IX-V complex","volume":"86","author":"Berndt","year":"2001","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/ATVBAHA.113.303113","article-title":"Platelet glycoprotein Ib-IX as a regulator of systemic inflammation","volume":"34","author":"Corken","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: platelet innate immune interactions and Thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41467-020-14958-x","article-title":"Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb","volume":"11","author":"Kohler","year":"2020","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150101","article-title":"Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein","volume":"132","author":"Li","year":"2022","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13054-016-1470-7","article-title":"Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury","volume":"20","author":"Aisiku","year":"2016","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaci.2020.09.018","article-title":"IL-6 serum levels predict severity and response to tocilizumab in COVID-19: an observational study","volume":"147","author":"Galvan-Roman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-023-04525-3","article-title":"Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis","volume":"27","author":"Rosenberger","year":"2023","journal-title":"Crit Care"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"18874","DOI":"10.1038\/s41598-021-98053-1","article-title":"Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches","volume":"11","author":"Liao","year":"2021","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1164\/rccm.200803-419OC","article-title":"Randomized clinical trial of activated protein C for the treatment of acute lung injury","volume":"178","author":"Liu","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1097\/00003246-200112000-00016","article-title":"von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury","volume":"29","author":"Ware","year":"2001","journal-title":"Crit Care Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1164\/rccm.200310-1434OC","article-title":"Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury","volume":"170","author":"Ware","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/SLA.0000000000002795","article-title":"Injury characteristics and von Willebrand factor for the prediction of acute respiratory distress syndrome in patients with burn injury: development and internal validation","volume":"270","author":"Afshar","year":"2019","journal-title":"Ann Surg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1097\/CCM.0000000000004918","article-title":"von Willebrand factor multimer formation contributes to immunothrombosis in coronavirus disease 2019","volume":"49","author":"Doevelaar","year":"2021","journal-title":"Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjh.17273","article-title":"Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID\u201019): evidence of acute and sustained endothelial cell activation","volume":"192","author":"Ward","year":"2021","journal-title":"Br J Haematol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"H2128","DOI":"10.1152\/ajpheart.00107.2009","article-title":"Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding","volume":"297","author":"Cheng","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3324\/haematol.2018.215145","article-title":"Appropriation of GPIbalpha from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation","volume":"105","author":"Chimen","year":"2020","journal-title":"Haematologica"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/j.1537-2995.2010.02669.x","article-title":"Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or Plasmalyte","volume":"50","author":"Slichter","year":"2010","journal-title":"Transfusion"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3324\/haematol.2022.281006","article-title":"Reduced platelet glycoprotein Ibalpha shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen","volume":"108","author":"Simeone","year":"2023","journal-title":"Haematologica"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1056\/NEJM198710223171701","article-title":"Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders","volume":"317","author":"Steinberg","year":"1987","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.healun.2013.08.013","article-title":"Platelet glycoprotein Ibalpha ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices","volume":"33","author":"Hu","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MOH.0000000000000826","article-title":"Shedding light on GPIbalpha shedding","volume":"31","author":"Debaene","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-023-02346-0","article-title":"Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial","volume":"24","author":"Haeberle","year":"2023","journal-title":"Respir Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-023-04330-y","article-title":"COVID-19 does not influence functional status after ARDS therapy","volume":"27","author":"Bernard","year":"2023","journal-title":"Crit Care"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \"sepsis-related problems\" of the European Society of Intensive Care Medicine","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13063-020-4163-0","article-title":"Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study","volume":"21","author":"Haeberle","year":"2020","journal-title":"Trials"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/s0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.phrs.2013.03.009","article-title":"Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach","volume":"72","author":"Daher Abdi","year":"2013","journal-title":"Pharmacol Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ckj\/sfaa024","article-title":"An introduction to joint models-applications in nephrology","volume":"13","author":"Chesnaye","year":"2020","journal-title":"Clin Kidney J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12873-022-00589-6","article-title":"The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Emerg Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v072.i07","article-title":"The R package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC","volume":"72","author":"Rizopoulos","year":"2016","journal-title":"J Stat Softw"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/aas.13105","article-title":"Fluid accumulation during acute kidney injury in the intensive care unit","volume":"62","author":"Berthelsen","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.athoracsur.2012.02.049","article-title":"An introduction to mixed models and joint modeling: analysis of valve function over time","volume":"93","author":"Andrinopoulou","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/s0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1182\/blood-2015-04-640649","article-title":"A paradigm shift in platelet transfusion therapy","volume":"125","author":"Cho","year":"2015","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1146\/annurev-physiol-030212-183752","article-title":"Platelets in lung biology","volume":"75","author":"Weyrich","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.1256478","article-title":"Neutrophils scan for activated platelets to initiate inflammation","volume":"346","author":"Sreeramkumar","year":"2014","journal-title":"Science"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"13464","DOI":"10.1038\/ncomms13464","article-title":"Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response","volume":"7","author":"Rossaint","year":"2016","journal-title":"Nat Commun"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","article-title":"Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","volume":"9","author":"Dixon","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"507151","DOI":"10.1155\/2015\/507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1172\/JCI114733","article-title":"Elevated Vonwillebrand-factor antigen is an early plasma predictor of acute lung injury in nonpulmonary Sepsis syndrome","volume":"86","author":"Rubin","year":"1990","journal-title":"J Clin Invest"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/a-2755-5477","article-title":"Von Willebrand factor at the crossroads of hemostasis and inflammation","volume":"46","author":"Yadegari","year":"2026","journal-title":"Hamostaseologie"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/ATVBAHA.122.318179","article-title":"Regulation of VWF (Von Willebrand factor) in inflammatory thrombosis","volume":"42","author":"Manz","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chest.2017.01.010","article-title":"Endothelial permeability and hemostasis in septic shock results from the ProCESS trial","volume":"152","author":"Hou","year":"2017","journal-title":"Chest"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"109657","DOI":"10.1016\/j.cbi.2021.109657","article-title":"Von Willebrand factor: a key glycoprotein involved in thrombo-inflammatory complications of COVID-19","volume":"348","author":"Choudhary","year":"2021","journal-title":"Chem Biol Interact"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"627579","DOI":"10.3389\/fimmu.2021.627579","article-title":"The outcome of critically ill COVID-19 patients is linked to Thromboinflammation dominated by the Kallikrein\/Kinin system","volume":"12","author":"Lipcsey","year":"2021","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0140-6736(94)92995-5","article-title":"Role of selectins in development of adult-respiratory-distress-syndrome","volume":"344","author":"Donnelly","year":"1994","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cyto.2014.06.010","article-title":"Elevated biomarkers of endothelial dysfunction\/activation at ICU admission are associated with sepsis development","volume":"69","author":"Vassiliou","year":"2014","journal-title":"Cytokine"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/SHK.0000000000000745","article-title":"Prevention or treatment of Ards with aspirin: a review of preclinical models and Meta-analysis of clinical studies","volume":"47","author":"Panka","year":"2017","journal-title":"Shock"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1711751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:34Z","timestamp":1777009294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1711751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":61,"alternative-id":["10.3389\/fmed.2026.1711751"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1711751","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1711751"}}